Impact of Non-Vitamin K Antagonist Oral Anticoagulants on the Change of Antithrombotic Regimens in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention — Soonil Kwon (2021) | RDL Network
Impact of Non-Vitamin K Antagonist Oral Anticoagulants on the Change of Antithrombotic Regimens in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
Article 2021 en
Authors
SK
Soonil Kwon
JJ
Jin‐Hyung Jung
EC
Eue-Keun Choi
Abstract
1 min read
Since the introduction of NOACs, the patterns of periprocedural antithrombotic regimens have changed rapidly toward more use of TAT, specifically with NOAC-based regimen. Appropriate stroke prevention with oral anticoagulants is still underutilized in patients with AF undergoing PCI in Korea.
Jan Steffel, Peter Verhamme, Tatjana Potpara, Pierre Albaladejo, Matthias Antz, Lien Desteghe, Karl Georg Hæusler, Jonas Oldgren, Holger Reinecke, Vanessa Roldán, Nigel Rowell, Peter Sinnaeve, Rónán Collins, A. John Camm, Hein Heidbüchel, Professor Gregory Lip, Jeffrey I. Weitz, Laurent Fauchier, Deirdre A. Lane, Giuseppe Boriani, Andreas Goette, Roberto Keegan,
Discussion(0)
No comments yet. Be the first to comment.